期刊文献+

坎地沙坦对自发性高血压大鼠胰岛素敏感性及炎性因子的影响 被引量:6

Effects of Candesartan on Insulin Sensitivity and Inflammatory Cytokines in Spontaneously Hypertensive Rats
暂未订购
导出
摘要 目的:探讨血管紧张素II受体拮抗剂(ARB)坎地沙坦对自发性高血压大鼠(SHR)炎性因子水平及胰岛素抵抗的影响。方法:30只SHR随机分为模型组、坎地沙坦高剂量组及低剂量组,10只WKY大鼠作为对照组,4组大鼠均给与果糖喂养,高、低剂量组同时给与对应剂量的坎地沙坦灌胃干预,8周后观察各组大鼠血压、胰岛素抵抗指数和炎性因子IL-2、IL-6、CRP的水平。结果:模型组大鼠血压、胰岛素抵抗指数及血清IL-6、CRP均较对照组升高,差异有统计学意义(P<0.01);坎地沙坦干预的大鼠与模型组大鼠相比,以上指标则明显降低,差异有统计学意义(P<0.05)。结论:坎地沙坦可能通过降低炎性因子IL-6、CRP的水平来改善胰岛素抵抗。 Objective: To investigate the effects of candesartan on inflammatory cytokines and insulin resistance in spontaneously hypertensive rats (SHR). Methods: Thirty SHR were randomly divided into model group ( group M), high dose of candesartan group ( group H) and low dose of candesartan group ( group L). Ten WKY rats served as control group. All rats were fed with fructose, while the rats in groups L and H were given corresponding doses of candesartan by garage. After 8 weeks, blood pressure, insulin resistance index and serum levels of inflammatory cytokines including IL-2, IL-6 and C-reactive protein (CRP) of rats in the 4 groups were detected. Results: The blood pressure, insulin resistance index and serum levels of IL-6 and CRP in group M were significantly higher than those of control (P 〈 0. 01 ). With the treatment of candesartan, the indicators mentioned above were decreased significantly in groups L and H (P 〈 0. 05 ). Conclusions: Candesartan may improve insulin resistance by reducing the serum inflammatory cytokines IL-6 and CRP levels.
出处 《贵阳医学院学报》 CAS 2012年第3期263-266,共4页 Journal of Guiyang Medical College
基金 北京市自然科学基金资助项目(7122171)
关键词 高血压 坎地沙坦 胰岛素 白细胞介素-2 白细胞介素-6 C反应蛋白质 hypertension candesartan insulin interleukin-2 interleukin-6 C-reactive protein
  • 相关文献

参考文献10

  • 1Alberti KG,Zimmet P,Shaw J. The metabolic syndromea new worldwide definition[J].The Lancet,2005,(366):1059-1062.doi:10.1016/S0140-6736(05)67402-8.
  • 2Ogihara T,Nakao K,Fukui T. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks:candesartan antihypertensive survival evaluation in Japan trial[J].Hypertension,2008,(51):393-398.doi:10.1161/HYPERTENSIONAHA.107.098475.
  • 3Julius S,Weber MA,Kjeldsen SE. The valsartan antihypertensive long-term uise evaluation,(VALUE) trial:outcomes in patients receiving monotherapy[J].Hypertension,2006,(03):385-391.doi:10.1161/01.HYP.0000236119.96301.f2.
  • 4Lastra G,Dhuper S,Johnson MS. Salt,aldosterone,and insulin resistance:impact on the cardiovascular system[J].Nat Rev Cardiol,2010,(07):577-584.
  • 5Mogi M,Iwai M,Horiuchi M. New insights into the regulation of angiotensin receptors[J].Current Opinion in Nephrology and Hypertension,2009,(02):138-143.
  • 6Stump CS,Henriksen EJ,Wei Y. The metabolic syndrome:role of skeletal muscle metabolism[J].Annals of Medicine,2006,(38):389-402.
  • 7Lumeng CN,Bodzin JL,Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization[J].Journal of Clinical Investigation,2007,(117):175-184.
  • 8Banks WA,Willoughby LY,Thomas DR. Insulin resistance syndrome in the elderly:assessment of functional,biochemical,metabolic,and inflammatory status[J].Diabetes Care,2007,(09):2369-3373.doi:10.2337/dc07-0649.
  • 9Cai D,Yuan M,Frantz DF. Local and systemic insulin resistance resulting from hepatic activation of IKKbeta and NF-kappaB[J].Nature Medicine,2005,(11):183-190.doi:10.1038/nm1166.
  • 10Guo F,Chen XL,Wng F. Role of Angiotensin Ⅱ Type 1 Receptor in Angiotensin Ⅱ-Induced Cytokine Production in Macrophages[J].Journal of Interferon & Cytokine Research,2011,(04):351-361.doi:10.1007/s11604-009-0418-0.

同被引文献47

  • 1Lastra G, Dhuper S, Johnson MS, et al. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol,2010,7:577- 584.
  • 2De Filippo G, Rendina D, Strazzullo P. Childhood obesity, oth er cardiovascular risk factors, and premature death. N Engl J Med,2010,362:1841 -1842.
  • 3Virdis A,Duranti E,Taddei S. Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin Ⅱ. Int J Hy pertens,2011,2011:916310.
  • 4Stump CS, Henriksen EJ, Wei Y, et al. The metabolic syn drorne: role of skeletal muscle metabolism. Ann Med, 2006, 38:389 -402.
  • 5Anfossi G,Russo I,Doronzo G, et al. Contribution of insulin resistance to vascular dysfunction. Arch Physiol Biochem, 2009,115:199 -217.
  • 6Zhou MS, Schulman 1H, Raij L. Role of angiotensin Ⅱ and oxidative stress in vascular insulin resistance linked to hyper tension. Am J Physinl Heart Circ Physiol, 2009,296:H833- H839.
  • 7Satirapoi B, I.eelasiri K, Supasyndh O, et al. Short tern, ad ministration of an angiotensin Ⅱ receptor blocker in patients with long term hemodialysis patients improves insulin resist ance. J Med Assoc Thai,2014,97:574- 581.
  • 8Ohshima K,Mogi M,Jing F,et al. Direct angiotensin Ⅱ type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPAR7 activation. PLoS One, 2012, 7: c48378.
  • 9Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin re sistance. J Clin Invest,2006,116:1793 -1801.
  • 10Mahfouz R, Khoury R, Blaehnio Zabielska A, et al. Charac terising the inhibitory actions of eeramide upon insulin signa ling in different skeletal muscle cell models: a mechanistic in sight. PLoS One, 2014,9 :e101865.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部